Background: To investigate recurrence rates and fertility outcomes of patients with borderline ovarian tumors (BOTs) treated with fertility-sparing surgery. Methods: This was a retrospective study. All women with BOTs from 2000 to 2006 were evaluated. Clinical outcomes were compared among groups that underwent radical, unilateral salpingo-oophorectomy, or ovarian cystectomy. The effects of clinical characteristics on recurrence were analyzed by independent t test, chi-square test, and Cox proportional hazard model. Results: After a mean follow-up period of 56.5 months, all 61 patients were alive. Seven (11.5%) had developed disease recurrence, and all were in the fertility-sparing group. Of these, five were in the cystectomy-only group and ...
International audience(1) Background: although most patients with epithelial ovarian cancer (EOC) un...
Objective This study was performed to assess the feasibility of conservative treatment for stage II ...
Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an indep...
AbstractBackgroundTo investigate recurrence rates and fertility outcomes of patients with borderline...
: Borderline ovarian tumors (BOTs) account for approximately 15% of all epithelial ovarian cancers. ...
Objective: Borderline ovarian tumours (BOTs) are characterized by the presence of cellular prolifera...
OBJECTIVE: To assess the safety of fertility-sparing treatment and the remaining chance of childbear...
To determine the oncological outcomes following fertility-sparing surgery (FSS) for the management o...
Objective: The aim was to evaluate the outcome of fertility-sparing treatment in ovarian borderline ...
OBJECTIVE: To evaluate the fertility and survival outcomes in young women with borderline ovarian tu...
This study examined treatment outcomes, including preserved fertility, menstrual regularity, and pre...
Abstract Background Fertility sparing surgery has been extensively performed among patients with bor...
AbstractObjectiveTo evaluate the feasibility of fertility-sparing surgery in treating advanced-stage...
OBJECTIVE: To outline the most recent information regarding conservative laparoscopic surgery for...
Ovarian borderline tumors (OBTs) are frequently diagnosed in women of reproductive age. There is no ...
International audience(1) Background: although most patients with epithelial ovarian cancer (EOC) un...
Objective This study was performed to assess the feasibility of conservative treatment for stage II ...
Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an indep...
AbstractBackgroundTo investigate recurrence rates and fertility outcomes of patients with borderline...
: Borderline ovarian tumors (BOTs) account for approximately 15% of all epithelial ovarian cancers. ...
Objective: Borderline ovarian tumours (BOTs) are characterized by the presence of cellular prolifera...
OBJECTIVE: To assess the safety of fertility-sparing treatment and the remaining chance of childbear...
To determine the oncological outcomes following fertility-sparing surgery (FSS) for the management o...
Objective: The aim was to evaluate the outcome of fertility-sparing treatment in ovarian borderline ...
OBJECTIVE: To evaluate the fertility and survival outcomes in young women with borderline ovarian tu...
This study examined treatment outcomes, including preserved fertility, menstrual regularity, and pre...
Abstract Background Fertility sparing surgery has been extensively performed among patients with bor...
AbstractObjectiveTo evaluate the feasibility of fertility-sparing surgery in treating advanced-stage...
OBJECTIVE: To outline the most recent information regarding conservative laparoscopic surgery for...
Ovarian borderline tumors (OBTs) are frequently diagnosed in women of reproductive age. There is no ...
International audience(1) Background: although most patients with epithelial ovarian cancer (EOC) un...
Objective This study was performed to assess the feasibility of conservative treatment for stage II ...
Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an indep...